102 related articles for article (PubMed ID: 11848445)
21. Signaling through PI3K/Akt mediates stretch and PDGF-BB-dependent DNA synthesis in bladder smooth muscle cells.
Adam RM; Roth JA; Cheng HL; Rice DC; Khoury J; Bauer SB; Peters CA; Freeman MR
J Urol; 2003 Jun; 169(6):2388-93. PubMed ID: 12771803
[TBL] [Abstract][Full Text] [Related]
22. Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism.
Weber A; Köppen HO; Schrör K
Thromb Res; 2000 Jun; 98(5):461-6. PubMed ID: 10828486
[TBL] [Abstract][Full Text] [Related]
23. Contrasting effects of platelet-derived growth factor (PDGF) isomers on mitogenesis, contraction and intracellular calcium concentration in human vascular smooth muscle.
Hafizi S; Nobin R; Allen SP; Chester AH; Yacoub MH
Acta Physiol Scand; 1998 Oct; 164(2):191-9. PubMed ID: 9805106
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors.
Watanabe S; Matsuda A; Suzuki Y; Kondo K; Ikeda Y; Hashimoto H; Umemura K
Br J Pharmacol; 2000 May; 130(2):307-14. PubMed ID: 10807667
[TBL] [Abstract][Full Text] [Related]
25. Modification of PI3K- and MAPK-dependent chemotaxis in aortic vascular smooth muscle cells by protein kinase CbetaII.
Campbell M; Trimble ER
Circ Res; 2005 Feb; 96(2):197-206. PubMed ID: 15591231
[TBL] [Abstract][Full Text] [Related]
26. Effect of serum withdrawal on the contribution of L-type calcium channels (CaV1.2) to intracellular Ca2+ responses and chemotaxis in cultured human vascular smooth muscle cells.
Patel MK; Clunn GF; Lymn JS; Austin O; Hughes AD
Br J Pharmacol; 2005 Jul; 145(6):811-7. PubMed ID: 15880143
[TBL] [Abstract][Full Text] [Related]
27. Role of E2F and ERK1/2 in STI571-mediated smooth muscle cell growth arrest and cyclin A transcriptional repression.
Sanz-González SM; Castro C; Pérez P; Andrés V
Biochem Biophys Res Commun; 2004 May; 317(4):972-9. PubMed ID: 15094364
[TBL] [Abstract][Full Text] [Related]
28. Antimitogenic effects of trapidil in coronary artery smooth muscle cells by direct activation of protein kinase A.
Bönisch D; Weber AA; Wittpoth M; Osinski M; Schrör K
Mol Pharmacol; 1998 Aug; 54(2):241-8. PubMed ID: 9687564
[TBL] [Abstract][Full Text] [Related]
29. Platelet-derived growth factor stimulated vascular smooth muscle cell proliferation and its molecular mechanism.
Li J; Huang SL; Guo ZG
Acta Pharmacol Sin; 2000 Apr; 21(4):340-4. PubMed ID: 11324463
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneity in the response of vascular smooth muscle to heparin: altered signaling in heparin-resistant cells.
Templeton DM; Zhao Y; Fan MY
Cardiovasc Res; 2000 Jan; 45(2):503-12. PubMed ID: 10728372
[TBL] [Abstract][Full Text] [Related]
31. Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet-derived growth factor.
Benitz WE; Lessler DS; Coulson JD; Bernfield M
J Cell Physiol; 1986 Apr; 127(1):1-7. PubMed ID: 2420809
[TBL] [Abstract][Full Text] [Related]
32. High density lipoproteins induce cell cycle entry in vascular smooth muscle cells via mitogen activated protein kinase-dependent pathway.
Nofer JR; Junker R; Pulawski E; Fobker M; Levkau B; von Eckardstein A; Seedorf U; Assmann G; Walter M
Thromb Haemost; 2001 Apr; 85(4):730-5. PubMed ID: 11341512
[TBL] [Abstract][Full Text] [Related]
33. Effects of KTJ740, a novel antithrombotic agent, on platelet-derived growth factor-induced rat aortic smooth muscle cell proliferation and cell cycle progression.
Kim TJ; Jeon J; Jin YR; Son DJ; Yoo HS; Hong JT; Ryu CK; Shin HS; Lee KH; Yun YP
J Cardiovasc Pharmacol; 2007 May; 49(5):280-6. PubMed ID: 17513946
[TBL] [Abstract][Full Text] [Related]
34. Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs.
Williams MR; Ling S; Dawood T; Hashimura K; Dai A; Li H; Liu JP; Funder JW; Sudhir K; Komesaroff PA
J Clin Endocrinol Metab; 2002 Jan; 87(1):176-81. PubMed ID: 11788644
[TBL] [Abstract][Full Text] [Related]
35. Suppression of mitogen-activated protein kinase phosphatase-1 (MKP-1) by heparin in vascular smooth muscle cells.
Zhao Y; Xiao W; Templeton DM
Biochem Pharmacol; 2003 Sep; 66(5):769-76. PubMed ID: 12948857
[TBL] [Abstract][Full Text] [Related]
36. Thrombospondin-1 regulation of smooth muscle cell chemotaxis is extracellular signal-regulated protein kinases 1/2 dependent.
Gahtan V; Wang XJ; Willis AI; Tuszynski GP; Sumpio BE
Surgery; 1999 Aug; 126(2):203-7. PubMed ID: 10455885
[TBL] [Abstract][Full Text] [Related]
37. COP-1, a member of the CCN family, is a heparin-induced growth arrest specific gene in vascular smooth muscle cells.
Delmolino LM; Stearns NA; Castellot JJ
J Cell Physiol; 2001 Jul; 188(1):45-55. PubMed ID: 11382921
[TBL] [Abstract][Full Text] [Related]
38. Fucoidan is a non-anticoagulant inhibitor of intimal hyperplasia.
McCaffrey TA; Falcone DJ; Borth W; Brayton CF; Weksler BB
Biochem Biophys Res Commun; 1992 Apr; 184(2):773-81. PubMed ID: 1315533
[TBL] [Abstract][Full Text] [Related]
39. Isolation and characterization of a macrophage-derived heparin-binding growth factor.
Besner G; Higashiyama S; Klagsbrun M
Cell Regul; 1990 Oct; 1(11):811-9. PubMed ID: 2088527
[TBL] [Abstract][Full Text] [Related]
40. Differential mitogenic effects of PDGF isoforms and heparin on human vascular smooth muscle cells.
Refson JS; Schachter M; Patel MK; Wolfe JH; Sever P
Biochem Soc Trans; 1995 May; 23(2):173S. PubMed ID: 7672199
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
